SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-24-000027
Filing Date
2024-02-05
Accepted
2024-02-05 08:00:18
Documents
17
Period of Report
2024-02-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 RE AUTOLOGOUS STEM CELL THERAPY POSTER brt8k2524.htm   iXBRL 8-K 28543
2 PRESS RELEASE ex99_1.htm EX-99.1 11956
3 POSTER ex99_2.htm EX-99.2 518
7 poster.jpg GRAPHIC 1367700
  Complete submission text file 0001021771-24-000027.txt   2060866

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA brtx-20240205.xsd EX-101.SCH 3884
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20240205_lab.xml EX-101.LAB 22547
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20240205_pre.xml EX-101.PRE 16057
18 EXTRACTED XBRL INSTANCE DOCUMENT brt8k2524_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 24593988
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)